The protective effect of myricetin against tert-butylhydroperoxide (t-BHP) induced oxidative stress in human erythrocytes was investigated. Incubating erythrocytes with t-BHP (10 -5 M) caused development of oxidative stress, as evidenced by significant (p < 0.05) increase in erythrocyte malondialdedyde (MDA) and protein carbonyl content, and decrease in intracellular reduced glutathione (GSH), membrane sulphydryl (-SH) groups. Incubation of erythrocytes with myricetin, simultaneously with t-BHP, protected the erythrocytes from oxidative stress, an effect which was dose-dependent. The results demonstrate that myricetin attenuates t-BHP induced oxidative damage, suggesting that supplementation of diet with myricetin/myricetin rich food may be beneficial in all pathological conditions where the antioxidant system of the body is overwhelmed.
Myricetin (3,3',4',5,5',7-hexahydroxyflavone; Figure  1 ) is a polyphenolic compound present naturally in plants. Belonging to the flavonoid group of polyphenols, myricetin is ubiquitously present in foods including vegetables, fruits, tea and wine [1] . Reactive oxygen species (ROS) are continuously produced during cell metabolism. Under normal conditions they are scavenged and converted to nonreactive species by different intracellular, enzymatic and non enzymatic anti-oxidant systems such as catalase, peroxidase, superoxide dismutase, vitamins and reduced glutathione [2] . Overproduction or an ineffective elimination of ROS may induce oxidative stress and cause damage to all types of molecules like proteins, lipids and nucleic acids [3] .
Many in vitro and in vivo studies have demonstrated that several parameters of red blood cells are negatively affected by increased oxidative stress. In fact, changes in membrane fluidity and inactivation of membrane bound receptors and enzymes [4] , ionic parameters [5] , increase in lipid peroxidation [6] , oxidation of glutathione and protein sulphydryl (-SH) group [7] , activation of proteolysis and formation of protein carbonyls [8] have all been described following oxidative stress to erythrocytes.
There is overwhelming evidence to suggest that nutritional sources of antioxidants, such as fruits, vegetable, tea and wine would attenuate tissue damage caused by oxidative challenges [9] . Polyphenolic compounds, abundant in these nutritional sources, could play a major role in enhancing the antioxidant system [10, 11] .
Several in vivo and in vitro studies have focused on various biological effects of myricetin. Studies suggest that myricetin possesses many beneficial health properties, including anticarcinogenic, antimutagenic and anti-inflammatory effects [12, 13] . Many of the biological actions of this flavonoid have been attributed to its antioxidant properties [1, 14] .
The present study was undertaken to evaluate the antioxidant effect of myricetin on markers of Oxidative stress is an unavoidable consequence of life in an oxygen-rich atmosphere. ROS are generated as a by-product of aerobic metabolism and exposure to various natural as well as synthetic toxicants. A certain amount of oxidative damage takes place even under normal conditions; however, the rate of this damage increases during the aging and other pathological events, as the efficiency of antioxidative and repair mechanisms decreases, leading to the condition of oxidative stress [15, 16] .
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The erythrocyte membrane is prone to lipid peroxidation under oxidative stress that involves cleavage of polyunsaturated fatty acids at their double bonds leading to the formation of MDA. The attack by ROS against proteins modifies amino acid (lysine, arginine, proline, and histidine) residues generating carbonyl moieties, which have been identified as an early marker for protein oxidation and is used as a measure of protein damage [8] .
Subjecting erythrocytes to oxidative stress (in vitro) by incubating them with tert-butylhydroperoxide (t-BHP) caused a significant increase in the MDA level and protein carbonyl group content above the basal values. Incubation of erythrocytes with myricetin showed the significant protection against the t-BHP-induced oxidative stress, as evidenced by the decrease in the MDA level ( Figure 2 ) and protein carbonyl group content ( Figure 3 ). We observed that the effect of myricetin is dose/concentration dependent.
Erythrocytes are highly susceptible to oxidative damage due to the high polyunsaturated fatty acid content of their membranes and the high cellular concentration of oxygen and hemoglobin, a potentially powerful promoter for the oxidative processes. Increased erythrocyte MDA level is known to cause decrease in the membrane fluidity of the membrane lipid bilayer and increased osmotic stability of the cell [17] . High concentration of MDA in erythrocytes is a marker of the cellular oxidative damage observed in stress or in pathological conditions, including aging [18] . Oxidative modification of proteins, considering their multiple functions, unlike lipid peroxidation, can be selective and specific. Use of protein carbonyls as an index of oxidative stress has some advantages in comparison with the measurement of other oxidation products because of the relative early formation and the relative stability of carbonylated proteins [19] . Accumulation of protein carbonyls is associated with a number of diseases, including amyotrophic lateral sclerosis, Alzheimer's disease, respiratory distress syndrome, muscular dystrophy and rheumatoid arthritis [20] .
Subjecting erythrocytes to oxidative stress (in vitro) by incubating them with t-BHP caused a significant decrease in the intracellular GSH level Treatment with myricetin showed significant protection at concentrations above 0.1 microM (**p < 0.01, ***p < 0.05, with respect to t-BHP alone). GSH content is expressed in mg/mL PRBC.
and membrane -SH content compared with basal values. Incubation of erythrocytes/membrane with myricetin resulted in significant protection against the t-BHP-induced oxidative stress, as evidenced by the increase in GSH level ( Figure 4 ) and membrane -SH content ( Figure 5 ). We observed that the effect of myricetin is dose/concentration dependent.
Reduced glutathione is a major intracellular nonprotein sulphydryl compound. GSH has many biological functions, including maintenance of membrane protein -SH groups in the reduced form, the oxidation of which can otherwise cause altered cellular structure and function. A decreased GSH content may predispose the cell to a lower defense against oxidative stress during several degenerative disease conditions. It has also been suggested that the long-term effect of small deficiencies in intracellular GSH may invite many complications in the body, like diabetes [21] .
The human erythrocyte is an easily accessible cell type, which is rich in sulphydryl functions; the importance of erythrocyte membrane -SH group to overall cellular redox balance has been emphasized [22] . Membrane oxidative damage has a great influence upon the membrane mechanical properties. Membrane -SH group oxidative damage may be an important molecular mechanism inducing changes of membrane microelasticities in whole cell deformability of erythrocytes under physiological and pathological oxidative stress [22] .
Our results show that myricetin can protect erythrocytes from oxidative stress under in vitro conditions. A similar condition of oxidative stress is experienced by the body in various disease conditions and we hypothesize that myricetin may provide protection against oxidative damage to membrane lipids and proteins under conditions that challenge the body's redox status. Protection of MDA and carbonyl formation in t-BHP induced oxidative stressed erythrocytes by myricetin in micromolar concentrations assumes significance because it has been reported that plasma flavonoid levels after the intake of flavonoids rich diet are usually in the micromolar range [23] . Our findings are also supported by the observations of Lee et al. [1] , according to which myricetin strongly attenuates the oxidative injury in osteoblasts evidenced by decrease in MDA and protein carbonyl contents.
Various studies advocate the beneficial health effects of myricetin. It is a strong inhibitor of the human P form phenolsulphotransferase, suggesting its potential use for clinically important drug interactions and as a chemopreventive agent in sulphation-induced carcinogenesis [24] . Indeed, myricetin has been shown to be a potent antimutagen and also has an inhibitory effect on platelet aggregation [25] . possible mechanism by which myricetin exerts these beneficial effects is thought to be its antioxidant activity [14, 26] .
Myricetin is considered as one of the most potent scavengers of ROS among the member of the flavonoid family. Interestingly, although myricetin occurs less commonly in foods than other flavonoids, and consequently is consumed at lower levels, it shows a higher antioxidant activity [27] .
Myricetin has also been shown to penetrate erythrocytes; it has been shown to prevent glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells. While most flavonoids are known to display antioxidant property, only myricetin, quercetin and fisetin (flavonoids in which the B ring is combined with a 2,3 double bond and a 4-oxo function of the C ring) have the ability to act as intracellular substrates for the plasma membrane redox system (PMRS) activity. The PMRS in erythrocytes represents a mechanism for celldependent reduction of extracellular oxidants and is an important process used by the erythrocytes to maintain the redox status of the plasma [28] .
Our studies demonstrate that t-BHP induced erythrocyte dysfunction is associated with oxidative stress observed in several disease conditions like diabetes, cardiovascular diseases and cancer. We provide evidence that myricetin can protect the erythrocytes from oxidation-induced damage through its strong antioxidant effect. Since myricetin is naturally present in many fruits and vegetables and is well absorbed in humans, a diet rich in myricetin may provide protection against degenerative diseases.
Experimental
Collection of blood, isolation of erythrocytes, preparation of red cell ghosts: Human venous blood from different healthy volunteers was obtained in heparin by venipuncture. The blood was centrifuged at 1800 g for 10 min at 4ºC. After the removal of plasma, buffy coat, and upper 15% of the packed red blood cells (RBCs), the RBCs were washed twice with cold PBS (0.9% NaCl, 10mM Na 2 HPO 4 , pH 7.4). Erythrocyte ghosts from leucocyte-free RBCs were prepared by the osmotic shock procedure of Marchesi and Palade [29] . The protocol of study was in conformity with the guidelines of the Institutional Ethical Committee.
Determination of malondialdehyde content:
Erythrocyte MDA level was measured according to the method of Esterbauer and Cheeseman [30] . Packed erythrocytes (0.2 mL) were suspended in 3 mL Krebs-Ringer phosphate buffer (KRPB), pH 7.4. The lysate (1 mL) was added to 1 mL of 10% trichloroacetic acid (TCA) and the mixture was centrifuged for 5 min at 1000 g. The supernatant (1 mL) was added to 1 mL of 0.67% thiobarbituric acid (TBA) in 0.05 mol/L NaOH and boiled for 20 min at a temperature greater than 90ºC. The solution was cooled and read against a complementary blank at 532 nm (OD1) and 600 nm (OD2). The net optical density (OD) was calculated after subtracting absorbance at OD2 from that at OD1. The concentration of MDA in erythrocytes was determined from a standard plot and expressed as nmol/mL of packed erythrocytes.
Determination of membrane protein carbonyls:
Erythrocyte membrane protein carbonyls were measured according to the procedure of Levine et al. [8] . Erythrocyte membrane samples in PBS (0.2 mL) were taken in two tubes as test and control. 2,4-Dinitrophenylhydrazine (DNPH) (4.0 mL of 10 mM) prepared in 2 M HCl was added to the test sample and 4.0 mL of 2 M HCl, alone, was added to the control sample. The contents were mixed thoroughly and incubated for 1 h in the dark at 37 O C. The tubes were shaken intermittently every 10 minutes to facilitate the reactions with proteins. After that, 20% TCA (w/v) was added to both tubes and the mixture left in ice for 10 mins. The tubes were then centrifuged at 3,500 rpm for 20 min to obtain the protein pellets. The supernatant was carefully aspirated and discarded. The protein pellets were washed three times with ethanol: ethyl acetate (1:1, v/v) solution to remove unreacted DNPH and lipid remnants. Finally, protein pellets were dissolved in 6 M guanidine hydrochloride and incubated for 10 mins at 37°C. The insoluble materials were removed by centrifugation. Carbonyl content was determined by taking the spectra of the supernatant at 370 nm. Each sample was read against the control. The carbonyl content was calculated by using an absorption coefficient (e) of 22,000 M -1 cm -1 and data were expressed in nmol/mg protein. The erythrocyte membrane protein content was determined by the method of Lowry et al. [31] , using BSA as standard.
Determination of erythrocyte GSH and membrane -SH group content: Erythrocyte GSH was measured following the method of Beutler et al. [32] and membrane-bound -SH group was estimated according to Kitajima's method [33] . Both methods were based on the ability of the SH group to reduce 5, 5'-dithiobis, 2-nitrobenzoic acid (DTNB) and form a yellow colored anionic product whose OD is measured at 412 nm. The concentration of GSH is expressed in mg per mL packed RBCs and was determined from a standard plot. The concentration of the -SH group is expressed as nmol/mg protein.
Induction of oxidative stress: Oxidative stress was induced in vitro by incubating washed erythrocytes/erythrocyte ghosts with 10 -5 M tertbutylhydroperoxide (t-BHP) with or without myricetin. The concentration of t-BHP was in the range used in previously published work [34] .
In vitro experiments with myricetin: Washed erythrocytes were suspended in 4 volumes of PBS containing 5 mmol/L glucose (pH 7.4). In vitro effects were evaluated by incubating the erythrocytes in the presence of myricetin at different doses at 37ºC for 60 min. After this time, the suspensions were immediately centrifuged at 1800 ×g, the RBC were washed twice with at least 50 volumes of PBS and then subjected to assay for MDA and GSH contents.
For the protein carbonyl group and -SH group estimation, erythrocyte ghosts (0.8-1.5 mg of protein) were incubated with myricetin at different doses in PBS (pH 7.4) for 1 h at 37°C prior to the estimation of membrane protein carbonyl and -SH. Parallel control experiments were also performed in which myricetin was replaced with an equal amount of solvent. Statistical analyses were performed using GraphPad Prism version 4.00 for Windows, GraphPad Software, San Diego California USA.
